Skip Navigation

About this blog

Case Disclosed is a blog written by students, supervising attorneys, directors, alumni, and friends of the Media Freedom & Information Access Clinic.

The views expressed on this blog belong to the author(s) and do not represent the views of Yale Law School or the Media Freedom and Information Access Clinic (MFIA).

[title_1]

NFOIC condemns search of Marion newspaper, calls for disclosure

August 14, 2023

July 27, 2023

On the passing of former NFOIC board president Mal Leary

May 26, 2023

NFOIC Board elects Jeff Roberts of Colorado to presidency

March 1, 2023

Case Disclosed

Authored by

Tagged by

The Risks of Trump's Proposal to Speed Up Drug Approvals

February 20, 2017

By Mark Doré

President Trump has signaled—often and recently—that he believes drug approval moves too slowly. Meeting with drug manufacturers at the White House on Jan. 31, Trump promised quick yes-or-no approval decisions on new drugs (and stressed the need for lower prices and U.S.-based manufacturing).

Health Canada’s Draft Guidance for Implementing Vanessa’s Law Limits Transparency

January 7, 2017

By Kathleen Choi

Canada’s public health department, Health Canada, is preparing to release its final guidance on the section of Vanessa’s Law designed to promote the transparency of information around pharmaceutical drugs.

New Disclosures Reflect NSLs’ Substantive First Amendment Flaws

December 19, 2016

By Hannah Bloch-Wehba

This year has seen a remarkable string of disclosures about national security letters (NSLs), the secret demands the FBI sends to financial and communications service providers compelling the disclosure of customer information and transactional data.

MFIA’s Lethal Injection Access Litigation: Statutory and Constitutional Strategies

November 23, 2016

By Allison Douglis

This post’s focus is on lethal injection access litigation that the Clinic has been carrying out in Missouri on behalf of five national and state news organizations.